JRP
Jasper Ridge Partners’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $363K | Hold |
7,454
| – | – | 0.01% | 114 |
|
2025
Q1 | $254K | Hold |
7,454
| – | – | 0.01% | 122 |
|
2024
Q4 | $293K | Hold |
7,454
| – | – | 0.01% | 118 |
|
2024
Q3 | $350K | Hold |
7,454
| – | – | 0.01% | 110 |
|
2024
Q2 | $403K | Hold |
7,454
| – | – | 0.01% | 110 |
|
2024
Q1 | $508K | Hold |
7,454
| – | – | 0.02% | 103 |
|
2023
Q4 | $467K | Hold |
7,454
| – | – | 0.02% | 104 |
|
2023
Q3 | $338K | Hold |
7,454
| – | – | 0.02% | 110 |
|
2023
Q2 | $418K | Hold |
7,454
| – | – | 0.02% | 103 |
|
2023
Q1 | $337K | Hold |
7,454
| – | – | 0.02% | 113 |
|
2022
Q4 | $303K | Hold |
7,454
| – | – | 0.02% | 110 |
|
2022
Q3 | $487K | Hold |
7,454
| – | – | 0.03% | 99 |
|
2022
Q2 | $453K | Hold |
7,454
| – | – | 0.03% | 102 |
|
2022
Q1 | $468K | Hold |
7,454
| – | – | 0.02% | 114 |
|
2021
Q4 | $565K | Hold |
7,454
| – | – | 0.02% | 110 |
|
2021
Q3 | $834K | Hold |
7,454
| – | – | 0.04% | 109 |
|
2021
Q2 | $1.21M | Hold |
7,454
| – | – | 0.06% | 89 |
|
2021
Q1 | $908K | Hold |
7,454
| – | – | 0.04% | 88 |
|
2020
Q4 | $1.14M | Hold |
7,454
| – | – | 0.05% | 75 |
|
2020
Q3 | $623K | Buy |
7,454
+1,970
| +36% | +$165K | 0.04% | 86 |
|
2020
Q2 | $403K | Hold |
5,484
| – | – | 0.03% | 87 |
|
2020
Q1 | $233K | Hold |
5,484
| – | – | 0.02% | 89 |
|
2019
Q4 | $334K | Hold |
5,484
| – | – | 0.02% | 86 |
|
2019
Q3 | $225K | Hold |
5,484
| – | – | 0.01% | 87 |
|
2019
Q2 | $258K | Buy |
+5,484
| New | +$258K | 0.01% | 88 |
|
2018
Q4 | – | Sell |
-5,484
| Closed | -$243K | – | 74 |
|
2018
Q3 | $243K | Hold |
5,484
| – | – | 0.01% | 70 |
|
2018
Q2 | $322K | Buy |
+5,484
| New | +$322K | 0.03% | 60 |
|